Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
MRI: Page 237
ACR warns of MRI reimbursement cuts in 2017
By
AuntMinnie.com staff writers
Reimbursement for radiology procedures may face significant reductions in 2017, according to an analysis by the American College of Radiology (ACR).
November 20, 2016
Switch to macrocyclic GBCAs reduces brain signals
By
Wayne Forrest
As more studies weigh the risks and benefits of gadolinium-based contrast agents (GBCAs), German researchers have discovered that switching from a linear GBCA to a macrocyclic GBCA reduced the level of residual signal intensity in the brains of patients who underwent multiple enhanced MRI scans with both types of agents.
November 20, 2016
Hitachi lands new Echelon Oval MRI installations
By
AuntMinnie.com staff writers
Hitachi Medical Systems America has landed new installations of its 1.5-tesla Echelon Oval MRI scanner.
November 17, 2016
Philips to unveil new neurology MR software at RSNA
By
AuntMinnie.com staff writers
Royal Philips plans to launch a suite of new MR software applications for neurology at the upcoming RSNA 2016 meeting.
November 16, 2016
AuntMinnie.com MRI Insider
By
Wayne Forrest
November 15, 2016
New trial will assess MR-HIFU, chemo drug combo
By
AuntMinnie.com staff writers
The Children's National Health System in Washington, DC, and oncology drug development firm Celsion have launched a clinical study to evaluate MR-guided high-intensity focused ultrasound (MR-HIFU) and a heat-activated chemotherapy drug for treating refractory or relapsed solid tumors in children and young adults.
November 15, 2016
MR contrast safety consortium takes shape
By
AuntMinnie.com staff writers
An Italian and a Dutch radiologist have launched the Gadolinium Retention Evaluation Consortium (GREC), a group that seeks to foster broad-based and international collaboration on addressing the safety of gadolinium-based contrast agents (GBCAs).
November 15, 2016
FDA OKs St. Jude's Proclaim spinal cord stimulation system
By
AuntMinnie.com staff writers
St. Jude Medical has received U.S. Food and Drug Administration (FDA) approval for full-body MR-conditional labeling for its Proclaim Elite spinal cord stimulation system.
November 13, 2016
FDA OKs Medtronic's defibrillator
By
AuntMinnie.com staff writers
Device manufacturer Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Claria MRI Quad cardiac resynchronization therapy defibrillator SureScan device for patients with heart failure.
November 13, 2016
Fonar boosts revenues, profits in Q1
By
AuntMinnie.com staff writers
MRI vendor Fonar posted a 6% increase in revenues in its 2017 first quarter.
November 10, 2016
MRI signals may show residual GBCA effects in the brain
By
Wayne Forrest
As researchers explore the potential long-term effects of gadolinium-based contrast agents (GBCAs), the direct measurement on MRI scans of T1 and T2 signal intensities in the brain may become a reliable method, according to a study published online October 31 in
Radiology
.
November 10, 2016
Gadobutrol causes 'very low' number of allergic-like reactions
By
Wayne Forrest
As radiologists and clinicians maintain their vigilance over the judicious use of gadolinium-based contrast agents for MRI scans, a new prospective study in
Radiology
has found that one agent, gadobutrol, resulted in a very low number of allergic-like reactions.
November 8, 2016
Previous Page
Page 237 of 624
Next Page